New Delhi, Sept. 6 -- Multibagger pharma stock Sudarshan Pharma will remain in focus in Monday's trading session after the board approved over 9.5% stake acquisition in Med Therapy Biotechnology Inc.

Sudarshan Pharma share price closed 1% higher on Friday, ending the session at Rs.39.42 apiece. The market capitalisation of Sudarshan Pharma stood at Rs.984.16 crore, as of 4 September.

In an exchange filing dated 5 September, Sudarshan Pharma said that the board has approved acquiring 24,23,675.64 equity shares, which is equivalent to a 9.50% stake, of Common Stock, par value $0.0001 per share of MedTherapy Biotechnology Inc.

According to the filing, Hemal Mehta, chairman & managing director, and Sachin Mehta, joint managing director and...